Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CERE Stock Summary
Top 10 Correlated ETFs
CERE
In the News
CERE Financial details
Company Rating
Neutral
Market Cap
7.6B
Income
-432.84M
Revenue
0
Book val./share
3.86
Cash/share
8.97
Dividend
-
Dividend %
-
Employees
334
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-16.93
Forward P/E
-
PEG
-11.22
P/S
-
P/B
24.38
P/C
4.64
P/FCF
-22.72
Quick Ratio
8.59
Current Ratio
8.72
Debt / Equity
0.67
LT Debt / Equity
0.67
-
-
EPS (TTM)
-2.67
EPS next Y
-
EPS next Q
-
EPS this Y
15.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
24.59%
-
-
-
-
SMA20
-
SMA50
-
SMA100
68%
Inst Own
40.68%
Inst Trans
0.46%
ROA
-48%
ROE
-100%
ROC
-0.56%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
19.59-43.59
52W High
-3.23%
52W Low
+119%
RSI
32
Rel Volume
0.4
Avg Volume
1.46M
Volume
584.75K
Perf Week
-1.23%
Perf Month
0.82%
Perf Quarter
81.47%
Perf Half Y
79.28%
-
-
-
-
Beta
1.489
-
-
Volatility
0.29%, 0.38%
Prev Close
0.73%
Price
41.61
Change
0.02%
CERE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -1.01 | -2.07 | -1.63 | -2.32 | -2.67 | |
Operating cash flow per share | -0.56 | -1.6 | -1.31 | -1.94 | -2.11 | |
Free cash flow per share | -0.56 | -1.86 | -1.38 | -1.96 | -2.14 | |
Cash per share | 0.63 | 5.21 | 4.14 | 5.9 | 9.66 | |
Book value per share | 0.61 | 5.22 | 4.24 | 3.45 | 4.16 | |
Tangible book value per share | 0.61 | 5.22 | 4.24 | 3.45 | 4.16 | |
Share holders equity per share | 0.61 | 5.22 | 4.24 | 3.45 | 4.16 | |
Interest debt per share | 0.22 | 0.45 | 0.27 | 2.51 | 2.86 | |
Market cap | 1.51B | 1.22B | 4.43B | 4.77B | 6.87B | |
Enterprise value | 1.46B | 870.39M | 4.27B | 5B | 6.36B | |
P/E ratio | -11.78 | -8.03 | -19.91 | -13.57 | -15.87 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -21.39 | -10.36 | -24.8 | -16.27 | -20.07 | |
PFCF ratio | -21.06 | -8.93 | -23.42 | -16.06 | -19.85 | |
P/B Ratio | 19.44 | 3.18 | 7.65 | 9.15 | 10.2 | |
PTB ratio | 19.44 | 3.18 | 7.65 | 9.15 | 10.2 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -39.67 | -5.84 | -19.41 | -13.6 | -14.4 | |
EV to operating cash flow | -20.67 | -7.39 | -23.92 | -17.06 | -18.58 | |
EV to free cash flow | -20.35 | -6.37 | -22.59 | -16.83 | -18.38 | |
Earnings yield | -0.08 | -0.12 | -0.05 | -0.07 | -0.06 | |
Free cash flow yield | -0.05 | -0.11 | -0.04 | -0.06 | -0.05 | |
Debt to equity | 0.37 | 0.09 | 0.06 | 0.71 | 0.67 | |
Debt to assets | 0.24 | 0.07 | 0.05 | 0.36 | 0.36 | |
Net debt to EBITDA | 1.39 | 2.35 | 0.71 | -0.63 | 1.16 | |
Current ratio | 5.85 | 13.22 | 13.59 | 12.48 | 10.92 | |
Interest coverage | 0 | 0 | 0 | -38.24 | -42.33 | |
Income quality | 0.55 | 0.77 | 0.79 | 0.83 | 0.79 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | 0.16 | 0.06 | 0.01 | 0.01 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -6.21 | -47.59 | -3.85 | -0.81 | -0.68 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.73 | 15.58 | 12.46 | 13.42 | 15.81 | |
ROIC | -0.62 | -0.33 | -0.33 | -0.4 | -0.39 | |
Return on tangible assets | -1.06 | -0.34 | -0.32 | -0.35 | -0.35 | |
Graham Net | 0.29 | 4.38 | 3.34 | 2.62 | 6.17 | |
Working capital | 72.2M | 361.01M | 535.48M | 833.09M | 914.76M | |
Tangible asset value | 77.82M | 384.52M | 578.73M | 521.24M | 673.75M | |
Net current asset value | 44.09M | 329.81M | 467.83M | 409.07M | 437.39M | |
Invested capital | 0.37 | 0.09 | 0.06 | 0.71 | 0.67 | |
Average receivables | 0 | 0 | 364.5K | 1.39M | 3.67M | |
Average payables | 0 | 3.55M | 8.15M | 10.68M | 10.96M | |
Average inventory | 0 | 0 | -364.5K | -1.39M | -1.02M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 4.59K | 1.51K | 748.98 | 769.5 | |
Days of inventory on hand | 0 | 0 | -97.43 | -152.31 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0.08 | 0.24 | 0.49 | 0.47 | |
Inventory turnover | 0 | 0 | -3.75 | -2.4 | 0 | |
ROE | -1.65 | -0.4 | -0.38 | -0.67 | -0.64 | |
Capex per share | -0.01 | -0.26 | -0.08 | -0.03 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.59 | -0.67 | -0.63 | -0.61 | -0.76 | |
Operating cash flow per share | -0.56 | -0.61 | -0.49 | -0.46 | -0.56 | |
Free cash flow per share | -0.56 | -0.61 | -0.51 | -0.46 | -0.56 | |
Cash per share | 5.7 | 5.28 | 4.69 | 4.3 | 8.97 | |
Book value per share | 3.33 | 2.76 | 2.23 | 1.73 | 3.86 | |
Tangible book value per share | 3.33 | 2.76 | 2.23 | 1.73 | 3.86 | |
Share holders equity per share | 3.33 | 2.76 | 2.23 | 1.73 | 3.86 | |
Interest debt per share | 2.4 | 2.4 | 2.37 | 2.36 | 2.61 | |
Market cap | 4.93B | 3.82B | 4.99B | 3.44B | 7.4B | |
Enterprise value | 5.16B | 4.03B | 5.18B | 3.65B | 6.89B | |
P/E ratio | -13.29 | -9.16 | -12.54 | -8.92 | -13.95 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -56.38 | -40.25 | -64.57 | -47.34 | -75.99 | |
PFCF ratio | -56.09 | -40.11 | -62.89 | -47.01 | -75.29 | |
P/B Ratio | 9.46 | 8.85 | 14.24 | 12.6 | 10.99 | |
PTB ratio | 9.46 | 8.85 | 14.24 | 12.6 | 10.99 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -48.13 | -40.51 | -53.55 | -38.98 | -49.93 | |
EV to operating cash flow | -59.01 | -42.49 | -67.03 | -50.23 | -70.75 | |
EV to free cash flow | -58.71 | -42.34 | -65.29 | -49.88 | -70.11 | |
Earnings yield | -0.02 | -0.03 | -0.02 | -0.03 | -0.02 | |
Free cash flow yield | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | |
Debt to equity | 0.71 | 0.86 | 1.05 | 1.35 | 0.67 | |
Debt to assets | 0.36 | 0.4 | 0.41 | 0.45 | 0.36 | |
Net debt to EBITDA | -2.15 | -2.13 | -1.97 | -2.24 | 3.7 | |
Current ratio | 12.48 | 13.35 | 11.47 | 8.72 | 10.92 | |
Interest coverage | -18.02 | -15.46 | -36.68 | -42.1 | -52.73 | |
Income quality | 0.94 | 0.91 | 7.92 | -9.29 | 0.73 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0 | 0.03 | 0.01 | 0.01 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.35 | 0.09 | -1.52 | -0.35 | -0.6 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 6.67 | 6.43 | 5.64 | 4.88 | 8.12 | |
ROIC | -0.12 | -0.12 | -0.13 | -0.17 | -0.12 | |
Return on tangible assets | -0.09 | -0.11 | -0.11 | -0.12 | -0.11 | |
Graham Net | 2.53 | 2.1 | 1.23 | 0.82 | 5.73 | |
Working capital | 833.09M | 777.83M | 686.11M | 608.95M | 914.76M | |
Tangible asset value | 521.24M | 431.71M | 350.5M | 272.96M | 673.75M | |
Net current asset value | 409.07M | 342.15M | 207.82M | 138.79M | 437.39M | |
Invested capital | 0.71 | 0.86 | 1.05 | 1.35 | 0.67 | |
Average receivables | 1.44M | 2.62M | 3.67M | 3.77M | 4.35M | |
Average payables | 12.52M | 8.69M | 8.35M | 10.47M | 11.7M | |
Average inventory | 2.77M | -2.62M | -3.67M | -3.77M | -1.7M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 699.22 | 498.37 | 624.55 | 716.83 | 709.89 | |
Days of inventory on hand | -142.19 | -218.15 | -275.06 | -211.74 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.13 | 0.18 | 0.14 | 0.13 | 0.13 | |
Inventory turnover | -0.63 | -0.41 | -0.33 | -0.43 | 0 | |
ROE | -0.18 | -0.24 | -0.28 | -0.35 | -0.2 | |
Capex per share | 0 | 0 | -0.01 | 0 | -0.01 |
CERE Frequently Asked Questions
What is Cerevel Therapeutics Holdings, Inc. stock symbol ?
Cerevel Therapeutics Holdings, Inc. is a US stock , located in Cambridge of Ma and trading under the symbol CERE
What is Cerevel Therapeutics Holdings, Inc. stock quote today ?
Cerevel Therapeutics Holdings, Inc. stock price is $41.61 today.
Is Cerevel Therapeutics Holdings, Inc. stock public?
Yes, Cerevel Therapeutics Holdings, Inc. is a publicly traded company.